Top Healing Foods That Stop Ovarian Cancer in its Tracks

Ovarian cancer is one of the most deadly diseases out there. It is the fifth leading cause of cancer death among U.S. women — an astounding 14,000 out of 23,000 diagnosed each year, die. Ovarian cancer tends to be aggressive and generally has very few symptoms until it reaches an advanced stage. Fortunately, several natural remedies have proven to be exceptionally useful in both preventing and curing this silent killer. Ginger, ginkgo biloba, green tea and flaxseed are all remarkably effective at destroying ovarian cancer cells and tumors — hindering proliferation and increasing survival rates dramatically. Diet is extremely influential in preventing as well as healing ovarian cancer. Beyond consuming an abundant variety of fresh produce and limiting dairy, meat and sugar, certain foods specifically target ovarian cancer cells — demonstrating extraordinary success in defeating this life-threatening disease.

Click to read more ...

Canadian Researchers Discover New Evidence That Vitamin D Shuts Down Cancer Cells

Researchers at McGill University have discovered a molecular basis for the cancerpreventive effects of vitamin D, whereby its active form essentially shuts down cancer cells. People with higher blood levels of vitamin D live significantly longer than people who have low blood levels of the vitamin. The team, led by McGill professors John White and David Goltzman, of the Faculty of Medicine’s Department of Physiology, discovered that the active form of vitamin D acts by several mechanisms to inhibit both the production and function of the protein cMYC. cMYC drives cell division and is active at elevated levels in more than half of all cancers. Their results are published in the latest edition of Proceedings of the National Academy of Sciences.

Click to read more ...

Mobile phones can cause brain tumours, court rules.

A landmark court case has ruled there is a link between using a mobile phone and brain tumours, paving the way for a flood of legal actions.

By Richard Alleyne

The Telegraph UK, 19 Oct 2012

http://www.telegraph.co.uk/health/9619514/Mobile-phones-can-cause-brain-tumours-court-rules..html

Innocente Marcolini, 60, an Italian businessman, fell ill after using a handset at work for up to six hours every day for 12 years.

Now Italy's Supreme Court in Rome has blamed his phone saying there is a "causal link" between his illness and phone use, the Sun has reported.

Mr Marcolini said: "This is significant for very many people. I wanted this problem to become public because many people still do not know the risks.

"I was on the phone, usually the mobile, for at least five or six hours every day at work.

"I wanted it recognised that there was a link between my illness and the use of mobile and cordless phones.

RELATED ARTICLES

• Mobile phone users face ‘brain tumour pandemic’ 

   15 Jun 2010

• Mobile phones cause 'five-fold increase in brain cancer risk' 

   30 Jun 2011

• Mobile phones and wi-fi 'do not cause cancer' 

   18 Sep 2012

"Parents need to know their children are at risk of this illness."

British scientists have claimed there is insufficient evidence to prove any link to mobiles.

But the respected oncologist and professor of environmental mutagenesis Angelo Gino Levis gave evidence for Mr Marcolini — along with neurosurgeon Dr Giuseppe Grasso.

They said electromagnetic radiation emitted by mobile and cordless phones can damage cells, making tumours more likely.

Prof Levis told The Sun: "The court decision is extremely important. It finally officially recognises the link.

"It'll open not a road but a motorway to legal actions by victims. We're considering a class action."

Mr Marcolini's tumour was discovered in the trigeminal nerve — close to where the phone touched his head.

It is non-cancerous but threatened to kill him as it spread to the carotid artery, the major vessel carrying blood to his brain.

His face was left paralysed and he takes daily morphine for pain.

Alasdair Philips of Powerwatch, which campaigns for more research on mobile use, said: "This is an interesting case and proves the need for more studies.

"People should limit mobile and cordless use until we know more."

The World Health Organisation urged limits on mobile use last year, calling them a Class B carcinogen.

But a spokesman for Britain's Health Protection Agency said: "The scientific consensus is that mobile phones do not cause cancer."

International radiation biology expert Michael Repacholi said: "Studies show no evidence of cancer. But if you are worried, use a headset, hands-free or loudspeaker."

Media lawyer Mark Stephens said the verdict could "open the floodgates" — even though there is no direct obligation on British courts to follow the Italians' lead.

He said: "It is possible people will begin legal action here, but I think the chances of success are less. I think they'll join any class action in Italy."

'Miracle grass' encourages longevity while dispelling disease

 More potent than ginseng, jiaogulan is a powerful antidote to aging, cancer, cardiovascular disease, stress and fatigue. It even helps to maintain proper weight. Known as an immortality elixir, this herb has been used for centuries throughout Asia. Jiaogulan is a top notch tonic for modern life too -- a true herbal champion for healthy and dynamic living.

First recorded in the Materia Medica for the Salvation of Starvation during the Ming Dynasty in China, jiaogulan (Gynostemma pentaphyllum) was the go-to herb for a variety of ailments. Often referred to as 'miracle grass,' jiaogulan has a long history of use. Containing four times the amount of saponins compared to ginseng, jiaogulan is an extraordinary adaptogen. American scientists have found it to be one of the top 10 most effective anti-aging herbs in the world.

The secret to longevity and absence of disease

The Chinese mountainous region of Guizhou is famous for its sheer number of centenarians. After 10 years of research, scientists discovered a common link among these long-lived people: daily consumption of sweet tasting jiaogulan tea. The centenarians also had very low incidences of Alzheimer's, cancer, diabetes and high blood pressure. Researchers believe such disease-free longevity is due to the abundance of antioxidants and saponins found in the herb.

Jiaogulan is also recognized as a general health elixir that supports endurance and strength while alleviating fatigue. Furthermore, it has been used with great success in treating the common cold and other infectious diseases.

Formidable anti-cancer tonic

Jiaogulan works on several levels to prevent and heal cancer. As an exceptional source of antioxidants, jiaogulan scavenges free radicals within the body -- minimizing DNA mutations that lead to tumors. The saponins present in jiaogulan also limit the growth of cancer by reacting with the cholesterol rich membranes surrounding rogue cells. Jiaogulan increases white blood cell counts too. In a Chinese study, cancer patients who had suppressed white blood cell activity due to radiation therapy, were given either jiaogulan, an herbal blend or a generic health tonic. Those who took jiaogulan, more than doubled their white blood cell count in an average of five days with almost 94 percent effectiveness.

Incomparable adaptogen

Adaptogens by their very nature have no side effects and only restore balance where needed. Jiaogulan may be the most powerful adaptogen of all as it contains over 100 saponins. Keep in mind the important influence saponins have on health -- regulating cholesterol, reducing cancer risk while enhancing immunity.

Through its adaptogenic properties, jiaogulan supports equilibrium within the body. If an individual needs to shed extra pounds, jiaogulan can help. Interestingly, the reverse is also true. If someone is underweight, the herb will assist in correcting that imbalance as well. Additionally, jiaogulan will regulate cholesterol and blood pressure whether too high or low. The nervous system is similar -- if anxiety ridden, jiaogulan has a calming effect; if dullness is present, the herb is energizing.

It is important to note that jiaogulan grown in Southeast Asia is often contaminated with heavy metals. Always chose organic, sustainably grown varieties to avoid potential toxins.

For those seeking youthfulness, health and vibrancy, jiaogulan might just be the answer. As an unbeatable adaptogen and supreme source of antioxidants as well as saponins, jiaogulan is a tasty way to enjoy the sweet life.

Sources for this article include:

"Jiao Gu Lan (Gynostemma pentaphyllum): The Chinese Rasayan-Current Research Scenario" R.N. Mishra, Dharnidhar Joshi, International Journal of Research in Pharmaceutical and Biomedical Sciences. Retrieved on October 8, 2012 from:http://www.ijrpbsonline.com/files/RV12.pdf

"Adaptogens: Herbs for Strength, Stamina, and Stress Relief" David Winston and Steven Maimes, Inner Traditions * Bear & Company.

"Jiaogulan the Chinese Herb of Immortality" Danica Collins, Underground Health Reporter. Retrieved on October 8, 2012 from: http://undergroundhealthreporter.com

"Gynostemma" Herbs List, June 20, 2011. Retrieved on October 8, 2012 from: http://www.herbslist.net/gynostemma.html

"Jiaogulan" Immortalitea. Retrieved on October 8, 2012 from: http://www.jiaogulan.org/category/jiaogulan-research/page/2/

"Gynostemma tea boosts heart health" Celeste M. Smucker, MPH, PhD, Natural News, March 19, 2011. Retrieved on October 8, 2012 from: http://www.naturalnews.com/031749_gynostemma_longevity.html

"Saponins" Phytochemicals. Retrieved on October 8, 2012 from: http://www.phytochemicals.info/phytochemicals/saponins.php

http://www.naturalnews.com/037527_miracle_grass_longevity_anti-cancer.html

Sayer Ji -- Mammograms Linked To An Epidemic of Misdiagnosed Cancers

For most of the twentieth century, mastectomy was the first line treatment for Ductal Carcinoma In Situ(DCIS), and younger patients were more likely to undergo the procedure. Even after lumpectomy andradiotherapy were shown to be at least as effective for invasive cancer as mastectomy, still in 2002, 26% of DCIS patients were still receiving mastectomy.¹

The most common scenario today following diagnosis of DCIS is for the oncologist to recommend lumpectomy, followed by radiation and hormone suppressive therapies such as Arimidex and Tamoxifen. The problem here is that women are not being educated about the nature of DCIS or the concept of "non-progressive" breast cancers. There is still the black and white perception out there that you either have cancer, or do not have cancer.

In a poll on DCIS awareness published in 2000, 94% of women studied doubted even the possibility of non-progressive breast cancers.²  In other words, these women had no understanding of the nature of DCIS. And why would they? Major authorities frame DCIS as "pre-cancerous," implying its inevitable transformation into cancer. When the standard of care for DCIS is to suggest the same types of treatment used to treat invasive cancer, very few women are provided with the information needed to make an informed decision.

Early detection through x-ray mammography has been the clarion call of Breast Cancer Awareness campaigns for a quarter of a century now.  However, very little progress has been made in making the public aware about the crucial differences between non-malignant lesions/tumors and invasive or non-invasive cancers detected through this technology. When all forms of breast pathology are looked at in the aggregate, irrespective of their relative risk for harm, disease of the breast takes on the appearance of a monolithic entity that you either have, or don't have; they call it breast cancer.

The concept of a breast cancer that has no symptoms, which can not be diagnosed through manual palpation of the breast and does not become invasive in the vast majority of cases, might sound unbelievable to most women. However, there does exist a rather mysterious clinical anomaly known as Ductal Carcinoma In Situ (DCIS), which is, in fact, one of the most commonly diagnosed and unnecessarily treated forms of "breast cancer" today.

What women fail to understand—because their physicians do not know better or have not taken care to explain to them—is that they have a choice when diagnosed with DCIS. Rather than succumb to aggressive treatment with surgery, radiation and chemo-drugs, women can choose watchful waiting. Better yet, a radical lifestyle change can be focused on eliminating exposure to chemicals and radiation, as well as improved exercise and nutrition. This choice is not being made in most cases because the medical community is not informing their patients that there is such.  

Ductal Carcinoma In Situ (DCIS): Cancer or Benign Lesion?

Between 30-50% of new breast cancer diagnoses obtained through x-ray mammography screenings are classified as Ductal Carcinoma In Situ (DCIS).³  DCIS refers to the abnormal growth of cells within the milk ducts of the breast forming a calcified lesion commonly between 1-1.5 cm in diameter, and is considered non-invasive or "stage zero breast cancer," with some experts arguing for its complete re-classification as a non-cancerous condition.

Because DCIS is almost invariably asymptomatic and has no palpable lesions, it would not be known as a clinically relevant entity were it not for the use of x-ray diagnostic technology. Indeed, it was not until the development and widespread application of mammography in the early 1980s as the central push behind National Breast Cancer Awareness campaigns that rates of DCIS diagnosis began to expand to their present day epidemic proportions.^4,5 It is no wonder, therefore, that the United States, which has one of the highest x-ray mammography rates, also has the highest level of DCIS in the world. As of January 2005, an estimated one-half million U.S. women were living with a diagnosis of DCIS.⁶

Proponents of breast screenings claim they are saving lives through the early detection and treatment of DCIS, regarding it as a potentially life-threatening condition, indistinct from invasive cancers. They view DCIS a priori as  "pre-cancerous" and argue that, because it could cause harm if left untreated it should be treated in the same aggressive manner as invasive cancer. The problem with this approach is that while the rate at which DCIS progresses to invasive cancer is still largely unknown, the weight of evidence indicates that it is significantly less than 50%—perhaps as low as 2-4%. 

Indeed, the 10-year survival rates of patients with DCIS (96%-98%) post-treatment speaks volumes to the relatively benign nature of the condition.^7,8  Another study found that at the 40-year follow-up period 40% of DCIS lesions still had no signs of invasiveness.⁹  Adding even more uncertainty, another study showed that coexisting DCIS independently predicts lower tumor aggressiveness in node-positive luminal breast cancer, indicating its possibly protective role. ¹⁰

Watchful Waiting (Around Doing Nothing of Use)

A solid argument can be made that watchful waiting is the most appropriate response to the diagnosis of DCIS, and that in many cases DCIS would be better left over-diagnosed and under-treated. As one paper discusses:

"The central harm of screening is over-diagnosis—the detection of abnormalities that meet the pathologic definition of cancer but will never progress to cause symptoms." ¹¹

A solid body of evidence has emerged suggesting that when DCIS is left undiagnosed and untreated rarely will it become malignant. DCIS was in fact poorly named from the outset, as it is does not behave like most carcinomas (cancers).  Cancer, like the constellation named after it, derives from the Greek word for Crab, indicating the manner in which is expands outward in uncontrolled growth. In situ means exactly the opposite, "in place." An unmoving cancer is therefore a contradiction in terms. These problems with classification have not gone unnoticed in the medical journals: 

"Despite the presence of the word carcinoma, ductal carcinoma in situ (DCIS) is the poster child for this problem (a senior pathologist involved in developing classification systems confided to one of us that he regretted the use of the term carcinoma in DCIS). No one believes that DCIS always progresses to invasive cancer, and no one believes it never does. Although no one is sure what the probability of progression is, studies of DCIS that were missed at biopsy (1,2) and the autopsy reservoir (3) suggest that the lifetime risk of progression must be considerably less than 50%." ¹²

The true irony here is that while participation in x-ray mammography is considered by the public a form of breast cancer prevention and "watchful waiting," it has become—whether by design or accident—a very effective way of manufacturing breast cancer diagnoses and justifying unnecessary treatment. This is not unlike what has been seen with prostate cancer screenings that track Prostate Specific Antigen (PSA); the aggressive treatment of lesions/tumors identified through PSA markers may actually increase patient mortality relative to doing nothing at all. 

Women diagnosed with DCIS are simply not given the option to decline treatment. The problem is illustrated below:

"Because the 'best guess' is that most DCIS won't progress to invasive cancer, the risk of over-diagnosis would be expected to be greater than 50%. The problem with over-diagnosis is that it leads to overtreatment. Because it is impossible to determine which individuals are over-diagnosed, almost everyone gets treated as if they had invasive cancer." ¹³  

Over-diagnosis is a huge problem, discussed in greater depth here:

"Over-diagnosis plays havoc with our understanding of cancer statistics. Because over-diagnosis effectively changes a healthy person into a diseased one, it causes overestimations of the sensitivity, specificity, and positive predictive value of screening tests and the incidence of disease (13). As the MLP and a recent analysis of Surveillance, Epidemiology, and End Results (SEER)1 data illustrate (14), over-diagnosis also markedly increases the length of survival, regardless of whether screening or associated treatments are actually effective. However, over-diagnosis does not reduce disease-specific mortality because treating subjects with pseudo-disease does not help those who have real disease. Consequently, disease-specific mortality is the most valid end point for the evaluation of screening effectiveness." ¹⁴  

Ultimately DCIS over-diagnoses contribute to the appearance that conventional breast cancer screenings and treatments are more successful and less harmful than they actually are, while at the same time making the industry far more profitable than otherwise would be the case.  ∆

Sayer Ji is the founder of GreenMedInfo.com, the world's largest, open source and evidence-based natural medicine and toxicology database, with close to 20,000 indexed across 2500 Diseases and 1500 Substances. He can be reached at Sayerji@greenmedinfo.com

References

^{1, 10} Overdiagnosis and overtreatment of breast cancer: Rates of ductal carcinoma in situ: a US perspective. Breast Cancer Res. 2005 Nov. 11. PMID: 1657703

² US women's attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey. BMJ 320 : 1635 doi: 10.1136/bmj.320.7250.1635 (Published 17 June 2000)

^3.  The management of ductal carcinoma in situ of the breast. Endocrine-Related Cancer. 2011 8 33-45.

^4,6 NIH State-of-the-Science Conference. Diagnosis and Management of Ductal Carcinoma in Situ (DCIS), Sept. 2009 Source: http://consensus.nih.gov/2009/dcisstatement.htm

⁵ The Dark Side of Breast Cancer Awareness Month  GreenMedInfo.com. 2011 Oct 1.

⁷ Ductal carcinoma in situ (DCIS): are we overdetecting it? http://breast-cancer-research.com/content/6/S1/P23

⁸ Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Intern Med. 2000 Apr 10;160(7):953-8. PMID: 1761960

⁹ Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer.  Med Oncol. 2011 Oct 8. Epub 2011 Oct 8. PMID: 21983862

^{11, 12, 13}  The Sea of Uncertainty Surrounding Ductal Carcinoma In Situ – The Price of Screening Mammmography. Journal of The National Cancer Institute  2008 Feb. 12. PMID: 18270336

¹⁴  Overdiagnosis: An Underrecognized Cause of Confusion and Harm in Cancer Screening. Journal of The National Cancer Institute  2000 PMID: 10944539

Read more.. http://www.greenmedinfo.com/blog/mammograms-linked-epidemic-misdiagnosed-cancers

William Malaurie -- Yes, GMOs are poisonous!

*French researchers studied privately for two years, 200 rats fed GM corn. Tumors, serious diseases ... a massacre. And a bomb [for the] GMO industry. 

This is a real bomb that launches this September 19 to 15 hours, the very serious American journal "Food and Chemical Toxicology" - a benchmark for food toxicology - publishing the results of the experiment conducted by [the] team [of] French Gilles-Eric Seralini, professor of molecular biology at the University of Caen. A cluster bomb [for] scientific, medical, and industrial policy. It sprays indeed an official truth: the safety of genetically modified maize. 

Heavily toxic and often fatal

Even at low doses, the GM study proves heavily toxic and often lethal to rats. So much so that, if it were a drug, it should be suspended forthwith pending further investigations. Because it is the same GMO found on our plates through the meat, eggs or milk.

In 2006, this is a true thriller that begins this research, the project manager, Gilles-Eric Seralini discloses itself conclusions in a book to be published next week ("All guinea pigs", Flammarion, in bookstores September 26).
Codenamed Vivo

Until 2011, the researchers worked under conditions of quasi-underground. They have their encrypted emails and the Pentagon, have banned all phone conversation and even launched a study decoy as they feared a coup de Jarnac multinational seed.

The story of the operation - codenamed Vivo - [involves] the difficult recovery of GM maize seeds NK 603, owned [and] patented [by] Monsanto, through an agricultural college in Canada. Then harvested and the repatriation of "big jute bags" [via]the port of Le Havre in late 2007, before making croquettes in total secrecy and the selection of two hundred lab rats called "Sprague Dawley". [The result?] Chilling: "After less than a year of genetically modified maize menus differentiated says Professor Séralini, it was a slaughter among our rats, [of] which I had not imagined the magnitude." 

Serious diseases, mammary tumors

All groups of rats, whether fed with GM maize treated or untreated with Roundup herbicide, Monsanto, or fed with water containing low doses of herbicide found in GM fields are hit by a multitude of serious diseases in the 13th month of the experiment. In females, this is manifested by explosions chain mammary tumors that reach up to 25% of their weight. Males, are purifiers organs, liver and kidneys, which are marked with abnormalities or severe. With a frequency of two to five times greater than for rodents fed non-GM corn.

Comparison implacable rats GMO therefore trigger two to three times more tumors than non-GMO rats whatever their sex. At the beginning of the 24th month, that is to say at the end of their lives, 50% and 80% of females are affected GMOs against only 30% among non-GMO.

Above all, tumors occur much faster in rats GM: twenty months earlier in males, three months earlier in females. For an animal that has two years of life expectancy, the difference is considerable. For comparison, one year for a rodent is roughly the equivalent of forty years for a man ... 

Demand accountability

It is these strong conclusions Corinne Lepage , in a book that seems to Friday, September 21 ("The truth about GMOs, is our business", Editions Charles Léopold Mayer), intends to demand accountability from political and experts, French and European health agencies and the Brussels Commission, which have so long opposed by all means and the principle of a long-term study on the physiological impact of GMOs.

This battle, the former Minister of Ecology and First Vice-President of the Committee on Environment, Public Health and Food Safety in Strasbourg, the leading fifteen years in the Criigen (Committee for Independent Research and Information on genetic engineering) with Joel Spiroux and Gilles-Eric Seralini. A simple association 1901 which has yet been able to meet end to end funding of this research (3.2 million euros) that neither INRA, CNRS neither, nor any public agency had judged advisable to undertake.
A study funded by Auchan and Carrefour

How? Another surprise by asking the Swiss Foundation Charles Léopold Mayer. But the owners of the supermarkets (Carrefour, Auchan ..), who gathered for the occasion together. Since the mad cow disease, in fact they want to protect themselves from any new food scandal. So much so that it is Gérard Mulliez, founder of the Auchan Group, which provided the initial funding. 

The study by Professor Séralini portend a new murderous war between pro and anti-GMO. Health agencies they require urgently similar studies to verify the findings of French scientists? It would be the least. Monsanto, the largest seed firm global transgenic leave she do? Unlikely: its survival would be at stake for a single plant GMOs, there are hundreds of varieties. Implying at least a dozen studies from 100 to 150 million euros each!
The time of truth

Except that in this new confrontation, the debate can no longer be bogged down by the past. September 26 dice, everyone can see the film in the cinema shock Jean-Paul Jaud, "All guinea pigs?", Adapted from the book by Gilles-Eric Seralini, and the terrible images of rats stuffy in their tumors. Images that will go around the world and the Internet, as it will be broadcast on Canal + (the "Grand Journal" September 19) and France 5 (October 16 in a documentary). For GM, the era of doubt ends. The time of truth begins.

Read more.. http://bit.ly/UngEH0

S. D. Wells -- The $3 billion Human Genome Project was supposed to find the root causes of all diseases, but turned out to be a scientific boondoggle

To ferret out the genetic roots of common diseases like cancer and Alzheimer's and then generate treatments" was the true goal of the 10-year, $3 billion human genome project, or was it? Geneticists who were paid a very pretty penny to study the genetics of disease are claiming they are "back to square one" in knowing where to look for the roots of these diseases, including heart disease and diabetes. But are any of them really diseases at all?

Most diseases are actually contagious, infectious and/or genetic defects, but the four leading causes of death in America, for the most part, are not. So what's the real deal? In June 2000, President Clinton announced that the genome project would "Revolutionize the diagnosis, prevention and treatment of most, IF NOT ALL, human diseases." He then added, "You will see a complete transformation in therapeutic medicine." Remember that Clinton is the man who balanced the national budget.

"Genomics is a way to do science, not medicine," said Harold Varmus, former president of the Memorial Sloan Kettering Cancer Center in New York, who became director of the National Cancer Institute (NCI). Both organizations pay their presidents and CEO's massive salaries and bonuses, using up most of the public donated monies for administrative costs, all while burying cures for disease (http://just-say-no-to-chemo.blogspot.com). Varmus claims the findings have explained only a small part of the risk of getting a disease, and that scientists now fear even those could be "statistical illusions." (http://www.cancer.gov/aboutnci/director)

Read more.. http://www.naturalnews.com/037167_Human_Genome_Project_scientific_failure_disease.html

Lisa Cerda - Monsanto: A Modern Day Plague

Monsanto’s history is one steeped with controversial products, deadly consequences, massive cover ups, political slight of hand, and culminates as a modern day plague on humanity, a plague that is about to peak to biblical proportions. Created in 1901, the company started producing its first form of poison, the artificial sweetener saccharin. The rise in use of saccharin really began 70 years later. Monsanto had plenty of time for a realistic and long term study on the impact of saccharin on human health. Instead, Monsanto learned how to finagle political support and grow its empire despite the growing consensus that saccharin caused cancer.

No surprise then that the company continued on a path of controversy. Here’s a bullet point history.
•    Contributed to the research on uranium, for the Manhattan Project, during WWII.
•    Operated a nuclear facility for the U.S. government until the late 1980s.
•    Top manufacturer of synthetic fibers, plastics and polystyrene (EPA’s 5th ranked chemical production that generates the most hazardous waste).
•    A top 10 US chemical company.
•    Agriculture pesticides producer.
•    Herbicide producer – herbicides 2,4,5-T, Agent Orange, Lasso, and DDT.

•    Agent Orange (used in Vietnam), had the highest levels of dioxin and contaminated more than 3 million civilians and servicemen of which only partial compensation awarded.
•    Nearly 500,000 Vietnamese children were born deformed and never compensated.
•    Lasso was banned in USA, so weed killer “Roundup” is launched in 1976.
•    A major producer of both dioxins and polychlorinated biphenyls (PCBs), which generated many law suits and environmental cleanups
•    $180 million settlement for Vietnam War veterans exposed to Agent Orange
•    Fined $1.2 million for concealing the discharge of contaminated waste water
•    Ordered to pay $41.1 million due to hazardous waste dumping
•    Paid $600 million in settlement claims to more than 20,000 Anniston residents in Abernathy v. United States.
•    Produced GM cattle drug, bovine growth hormone (called rBGH or rBST)
•    Acquiring seed companies from the 1990’s and forward.
•    Monsanto Filed 144 lawsuits against struggling farmers and settled out of court with 700 farmers, for reportedly violating seed patents.  A full time staff of 75 Monsanto employees investigates patent infringement. They are dedicated solely to finding farms that have been contaminated by their unwanted seed. As of 2007, Monsanto was awarded in 57 recorded judgments against farmers a total of $21,583,431.99. Monsanto vs. Farmers.

Read More:

http://wakeup-world.com/2012/07/16/monsanto-a-modern-day-plague/

Healthy Habits Can Prevent Disease

Five new studies provide evidence to support simple steps we can take to prevent illness and improve our overall health. In the June issue of The American Journal of Medicine, researchers report on fish consumption to reduce the risk of colon cancer; the effectiveness ofhypnotherapy and acupuncture for smoking cessation; regular teeth cleaning to improve cardiovascular health; the effectiveness of primary care physicians in weight loss programs; and the use of low-dose aspirin to reduce cancer risk.

Colorectal cancer is the third leading cause of cancer death in the Western world. Research linking fish consumption and the risk of colorectal cancer has been inconclusive, although people who live in countries with high levels of fish consumption are known to develop the disease less frequently. Now, scientists from Xi'an, China, have reviewed the literature and find that eating fresh fish regularly reduces the risk of colorectal cancer by 12%. They evaluated 41 studies on fish consumption and colorectal cancer risk published between 1990 and 2011 and tracked cancer diagnoses. The protective effect of fish consumption is more prominent in rectal cancer than in colon cancer. The risk reduction for rectal cancer was as much as 21%, whereas the reduction for colon cancer was 4%.

"Despite the fact that colon and rectal cancer share many features and are often referred to as colorectal cancer,' they tend to demonstrate many different characteristics," notes lead author Daiming Fan, of the Fourth Military Medical University. "One possible reason for the difference may be because colon cancers are generally more molecularly diverse, whereas rectal cancers mostly arise via a single neoplastic pathway."

Read More:

http://www.sciencedaily.com/releases/2012/06/120604125501.htm

One in six cancers 'caused by treatable infections'

Bacteria, viruses and parasites cause around 2m cases of cancer in the world each year, experts believe.

Of the 7.5m global deaths from cancer in 2008, an estimated 1.5m may have been due to potentially preventable or treatable infections.

Scientists carried out a statistical analysis of cancer incidence to calculate that around 16% of all cancers diagnosed in 2008 were infection-related. The proportion of cancers linked to infection was three times higher in developing countries than in developed ones.

Key cancer-causing infectious agents include human papillomavirus (HPV), the gastric bug Helicobacter pylori and the hepatitis B (HBV) and C viruses.

These four were together believed to be responsible for 1.9m cases of cancer, mostly gastric, liver and cervical cancers.

Cervical cancer accounted for around half of infection-related women's cancers. In men, more than 80% of infection-related cancers affected the liver, stomach and colon.

Dr Catherine de Martel and Dr Martyn Plummer, from the International Agency for Research on Cancer in Lyon, wrote in the Lancet Oncology journal: "Infections with certain viruses, bacteria, and parasites are one of the biggest and preventable causes of cancer worldwide  … Application of existing public-health methods for infection prevention, such as vaccination, safer injection practice, or antimicrobial treatments, could have a substantial effect on future burden of cancer worldwide."

Read More:

http://www.guardian.co.uk/science/2012/may/09/cancers-treatable-infections/print